• March 7, 2021

Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD - Odessa American: Business

e-Edition Subscribe

Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD

Print
Font Size:
Default font size
Larger font size

Posted: Monday, February 22, 2021 11:52 am | Updated: 12:19 pm, Mon Feb 22, 2021.

MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Feb 22, 2021--

Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its dextroamphetamine transdermal system (“ATS”). Noven’s ATS, in 4.5mg/9 hours, 9.0 mg/9 hours, 13.5mg/9 hours and 18.0mg/9 hours dosage strengths, is an investigational therapy developed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) for patients six years and older. Currently, there is no amphetamine-based transdermal treatment option available for ADHD.

The NDA submission is supported by results from a multicenter, laboratory classroom study which evaluated the safety and efficacy of ATS in over 100 pediatric patients with ADHD.

“The submission of the ATS NDA for consideration by the FDA represents a significant step toward our goal of offering a new option for clinicians, caregivers and patients for the treatment of ADHD. If approved, this investigational product will provide the first transdermal patch available for the treatment of ADHD in adults,” said Joel Lippman, M.D., Chief Operating Officer and Chief Medical Officer, Noven Pharmaceuticals, Inc.

About Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products. Noven’s mission is to develop and offer pharmaceutical products that meaningfully benefit patients around the world, with a commitment to advancing patient care through transdermal drug delivery. Noven is a stand-alone operating subsidiary of Japan-based Hisamitsu Pharmaceutical Co., Inc., serving as Hisamitsu’s U.S. platform for prescription pharmaceuticals, and helping Hisamitsu bring the benefits of patch therapy to the world. For more information about Noven, visit http://www.noven.com/. For information about Hisamitsu, visit https://global.hisamitsu/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210222005754/en/

CONTACT: Monica Perez

Director – Corporate Affairs

Noven Pharmaceuticals, Inc.

305-253-1916

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA NEW JERSEY

INDUSTRY KEYWORD: FDA GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Noven Pharmaceuticals, Inc.

Copyright Business Wire 2021.

PUB: 02/22/2021 12:52 PM/DISC: 02/22/2021 12:52 PM

http://www.businesswire.com/news/home/20210222005754/en

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Clear
44°
Humidity: 63%
Winds: SE at 9mph
Feels Like: 39°

Your Extended Forecast

Today

weather
High 63°/Low 39°
Clear. Lows overnight in the upper 30s.

Tomorrow

weather
High 65°/Low 44°
Sunshine. Highs in the mid 60s and lows in the mid 40s.

monday

weather
High 71°/Low 52°
Partly cloudy and windy. Highs in the low 70s and lows in the low 50s.

tuesday

weather
High 77°/Low 54°
Cloudy. Highs in the upper 70s and lows in the mid 50s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.